Cervical cancer risk study for average-risk adults
Part of Cancer clinical trials.
This study aims to better understand who is most likely to develop cervical cancer. It uses a simple blood test and follow-up during colposcopy to improve screening for people at average risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a colposcopy (a test to look closely at your cervix).
- Your doctor considers you at 'average risk' for cervical cancer.
- You have never had cervical cancer or any other cancer (except certain minor skin cancers removed more than a year ago).
- You are not taking certain strong medications (like chemotherapy or drugs for rheumatoid arthritis) and haven't had a major injury, surgery, or blood transfusion in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.
This study tests if a simple blood or fluid test can find cancer early in people with a higher-than-average risk. If you have certain genetic mutations, a strong family history of cancer, or other high-risk conditions, you may be able to join.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
This trial is a low-risk cancer prevention study that enrolls adults to help support healthier choices and early prevention efforts. It may help you stay on track with prevention guidance through participating healthcare programs.
Hear when a new Cervical Cancer Susceptible Population Classification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.